Identification of Mutation in Exon2 of the NKX2.5 Gene in Bangladeshi Pediatric Patients with Congenital Hypothyroidism

##plugins.themes.bootstrap3.article.main##

  •   Marjia Khatun

  •   Sagana Shahreen Chowdhury

  •   Toufiq Hasan Khan

  •   Laila Anjuman Banu

Abstract

Context and rationale: Congenital hypothyroidism is a prevalent endocrine disease that may occur due to the alteration in the sequence of nucleotides of the NKX2.5 gene. Though congenital hypothyroidism is quite common among the Bangladeshi pediatric population, there are few studies on the genetic basis of this disease.


Objective: This study aimed to identify any mutation in the exon2 of the NKX2.5 gene in Bangladeshi pediatric patients with congenital hypothyroidism.


Methods: Forty (40) Bangladeshi pediatric patients with congenital hypothyroidism were recruited, the sociodemographic data were collected and analyzed, DNA was isolated, quantity and quality of DNA were checked, polymerase chain reaction (PCR) was done, the amplicons were visually validated by gel electrophoresis and cycle sequencing was done by Sanger sequencing. The raw chromatogram data were analyzed and compared with the NCBI database by BLAST (Basic Local Alignment Search Tool) search.


Results: Sanger sequencing revealed two types of alteration in the nucleotide sequence. Nine patients showed substitutions (c.1051G>T) and eight patients showed deletions (c.1143 delT-), and both substitution and deletion were present in four patients. This substitution and deletion occurred in the Sequence Tagged Site (STS) of the exon2 of the NKX2.5 gene and these are new variants and not reported in NCBI database.


Conclusion: In the present study, two types of variants were identified. So, further study to find out mutational status among Bangladeshi children might be helpful in enriching the database of mutational spectra of pediatric patients with congenital hypothyroidism.


Keywords: Congenital Hypothyroidism, Deletion, NKX2.5 gene, Sequence Tagged Site (STS), Substitution

References

Montanelli L & Tonacchera M, “Genetics and phenomics of hypothyroidism and thyroid dys- and agenesis due to PAX8 and TTF1 mutations,”Molecular & Cellular Endocrinology. 322. 64-71, 2010.

Hermanns, P, Grasberger, H, Refetoff, S &Pohlenz, J, “ Mutation in the NKX2.5 gene and the PAX8 promoter in a girl with thyroid dysgenesis,”J ClinEndocrinolMetabol. 96, 6, E977-E981, 2011.

Ramos, HE, Nesi-Franca, S, Boldarine, VT, Pereira, RM &Chiamolera, MI, Camachoo, CP, Graf, H, de Lacerda, L, Carvalho, GA &Maciel, RMB, “Clinical and molecular analysis of thyroid hypoplasia: A population-based approach in southern Brazil,” Thyroid. 19, 61–68, 2009.

Sadler, T.W 2016, Langman’s Medical Embryology, 13th edn, Library of Congress Cataloging-in publication Data, South Carolina.

Narumi, S, Muroya, K, Asakura, Y, Adachi, M & Hasegawa, T, “Transcription factor mutations and congenital hypothyroidism: Systematic genetic screening of a population-based cohort of Japanese patients,”J ClinEndocrinolMetabol. 95, 1981–1985,2010.

van Engelen, K, Mommersteeg, MTM, Baars, MJH, Lam, J, Ilgun, A, van Trotsenburg, ASP, Smets AMJB, Christoffels, VM, Mulder, BJM &Postma, AV, “The ambiguous role of NKX2-5 mutations in thyroid dysgenesis,” PLOS One. 7, 12, 2012.

National Center for Biotechnology Information (NCBI) 2017, Homo sapiens Annotation release 109, RefSeqGene on chromosome 5 GRCh38.

Khatami M, Heidari MM, Tabesh F, Ordooei M &Salehifar Z “Mutation analysis of NKX2.5 gene in Iranian pediatric patients with congenital hypothyroidism,”J PediatrEndocrinolMetabol.10, 1-6,2017.

Green, ED & Green, P, “Sequence tagged site content mapping of human chromosome: Theoretical consideration and early experience,”Genome Research. 1, 77-90,(1991).

Desmet, F. O. et al., “Human Splicing Finder: an online bioinformatics tool to predict splicing signals,” Nucleic Acid Res. 37, e67, 2009.

Agarwal V, Bell GW, Nam J, Bartel DP,“Predicting effective microRNA target sites in mammalian mRNAs,”eLife, 4:e05005, 2015.

Pickrell, J. K. et al.,“Understanding mechanisms underlying human gene expression variation with RNA sequencing,” Nature. 464, 768–772 ,2010.

Vejnar, C. E., &Zdobnov, E. M, “MiRmap: comprehensive prediction of microRNA target repression strength,”Nucleic acids research, 40(22), 11673-11683, 2012.

Dentice M, Cordeddu V, Rosica A, Ferrara AM, Santarpia L, Salvatore D, Chiovato L, Perri A, Moschini L, Fazzini C, Olivieri A, Costa P, Stoppioni V, Baserga M, De Felice M, Sorcini M, Fenzi G, Di Lauro R, Tartaglia M &Macchia PE,“Missence mutation in the transcription factor NKX2.5: A novel molecular event in the pathogenesis of thyroid dysgenesis,” JClinEndocrinolMetabol. 91, 4, 1428-1433, 2006.

Brust ES, Beltrao CB, Chammas MC, Watanabe T, Sapienza MT& Marui S,“Absence of mutations in PAX8, NKX2.5 and TSH receptor genes in patients with thyroid dysgenesis,”Arch BrazEndocrinolMetab,56, 173–177, 2012.

Cerqueira TL, Ramos Y, Strappa G, Martin DS, Jesus M, Gonzaga J, Ferreira P, Costa A, Fernandes V, Amorim T, Ladeia MA & Ramos H,“The c.63A>G polymorphism in the NKX2.5 gene is associated with thyroid hypoplasia in children with thyroid dysgenesis,”Arch EndocrinolMetab, 59, 562-567, 2015.

Downloads

Download data is not yet available.

##plugins.themes.bootstrap3.article.details##

How to Cite
Khatun, M., Chowdhury, S. S., Khan, T. H., & Banu, L. A. (2020). Identification of Mutation in Exon2 of the NKX2.5 Gene in Bangladeshi Pediatric Patients with Congenital Hypothyroidism. European Journal of Medical and Health Sciences, 2(5). https://doi.org/10.24018/ejmed.2020.2.5.487